References
- Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet. 2016;388(10055):2039–52.
- Shoji A, Yamanaka H, Kamatani N. A retrospective study of the relationship between serum urate level and recurrent attacks of gouty arthritis: evidence for reduction of recurrent gouty arthritis with antihyperuricemic therapy. Arthritis Rheum. 2004;51:321–5.
- Kuo CF, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015;74(4):661–7.
- Rai SK, Aviña-Zubieta JA, McCormick N, De Vera MA, Shojania K, Sayre EC, et al. The rising prevalence and incidence of gout in British Columbia, Canada:Population-based trends from 2000 to 2012. Semin Arthritis Rheum. 2017;46(4):451–6.
- Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol. 2010;20(5):413–9.
- Ministry of Health Labour and Welfare. Annual Health, Labor and Welfare Report 2015, Health and Medical Services. Available from: http://www.mhlw.go.jp/english/wp/wp-hw9/dl/02e.pdf.
- Hosoya T, Ohno I, Nomura S, Hisatome I, Uchida S, Fujimori S, et al. Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout. Clin Exp Nephrol. 2014;18(6):876–84.
- Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum. 2011;63(10):3136–41.
- Winnard D, Wright C, Taylor WJ, Jackson G, Karu LT, Gow PJ, et al. National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford). 2012;51(5):901–9.
- Choi HK, Atkinson K, Karlson EW, Curhan G. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. Arch Intern Med. 2005;165(7):742–8.
- Aune D, Norat T, Vatten LJ. Body mass index and the risk of gout: a systematic review and dose-response meta-analysis of prospective studies. Eur J Nutr. 2014;53(8):1591–601.
- Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.
- Trifirò G, Morabito P, Cavagna L, Ferrajolo C, Pecchioli S, Simonetti M, et al. Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study. Ann Rheum Dis. 2013;72(5):694–700.
- Wändell P, Carlsson AC, Ljunggren G. Gout and its comorbidities in the total population of Stockholm. Prev Med. 2015;81:387–91.
- Dehlin M, Drivelegka P, Sigurdardottir V, Svärd A, Jacobsson LT. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther. 2016;18(1):164.
- Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Zhang W, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2015;17(1):13.
- Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med. 1987;82(3):421–6.
- Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort . Arthritis Rheum. 2010;62(4):1069–76.
- Hakoda M. Recent trends in hyperuricemia and gout in Japan. Japan Med Assoc J. 2012;55(4):319–23.
- Ministry of Health, Labor and Welfare, Japan. Outline for the results of the National Health and Nutrition Survey Japan, Tokyo, Japan. 2007. Available from: http://www.nibiohn.go.jp/eiken/english/research/pdf/nhns2007.pdf
- Kumar AUA, Browne LD, Li X, Adeeb F, Perez-Ruiz F, Fraser AD, et al. Temporal trends in hyperuricaemia in the Irish health system from 2006–2014: A cohort study. PLoS One. 2018;13(5):e0198197.
- Terrill M, Riordan J. A survey of the assessment and management of gout in general practitioners and medical officers within the Illawarra Network, Australia. Int J Rheum Dis. 2017;20(8):990.
- Sarawate CA, Brewer KK, Yang W, Patel PA, Schumacher HR, Saag KG, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc. 2006;81(7):925–34.
- Robinson PC, Taylor WJ, Dalbeth N. An observational study of gout prevalence and quality of care in a National Australian General Practice population. J Rheumatol. 2015;42(9):1702–7.
- Yamanaka H. Japanese Society of Gout and Nucleic Acid Metabolism.Japanese guideline for the management of hyperuricemia and gout: second edition. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1018–29.
- Ichikawa N, Taniguchi A, Urano W, Nakajima A, Yamanaka H. Comorbidities in patients with gout. Nucleosides Nucleotides Nucleic Acids. 2011;30(12):1045–50.
- Hui M, Carr A, Cameron S, Davenport G, Doherty M, Forrester H, et al. British Society for Rheumatology guideline for the management of gout. Rheumatology (Oxford). 2017;56(7):e1–e20.
- Khanna D, Fitzgerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res. 2012;64(10):1431–46. 2012
- Wakasugi M, Kazama JJ, Narita I, Konta T, Fujimoto S, Iseki K, et al. Association between hypouricemia and reduced kidney function: a cross-sectional population-based study in Japan. Am J Nephrol. 2015;41(2):138–46.
- Hak AE, Choi HK. Menopause, postmenopausal hormone use and serum uric acid levels in US women–the Third National Health and Nutrition Examination Survey. Arthritis Res Ther. 2008;10(5):R116.
- Tamada T, Iwasaki H. Age at natural menopause in Japanese women (in Japanese.). Acta Obst Gynaec Jpn. 1995;47:947–52.
- Ministry of Health, Labor and Welfare, Japan. Comprehensive Survey of Living Conditions. Rate of Outpatients (Per 1000 Population) by Type of Diseases, Gender and Age Group (Multiple Answer), 2013.
- Kawasaki T, shichikawa K. Prevalence of gout in population-based epidemiological study in Japan. Ann Rheum Dis. 2007;66(2):S232.